■ 学術雑誌
|
原著
|
|
1.
|
Takuma Karasuyama, Gozo Kiguchi, Keiko Kubota, Kazuyuki Nagai, Osamu Takeyama：
Retroperitoneal-First Laparoscopic Approach (Retlap) for Bile Duct Resection in Pancreaticobiliary Maljunction (PBM): A Novel and Reasonable Approach to Intrapancreatic Bile Duct.
Annals of surgical oncology
33
(6)
：5833
-5834
, 2026
|
|
2.
|
Minha Choi, Shin Hwang, Masaki Kaibori, Minkyeong Jo,：
Prediction of microvascular invasion and post-resection prognosis using ADV, AFP-PIVKA-II, and MoRAL scores in hepatocellular carcinoma patients: an international multicenter cohort study with 9,061 patients.
Annals of surgical treatment and research
110
(5)
：317
-330
, 2026
|
|
3.
|
Keisuke Kazama, Norio Yukawa, Takeshi Yamada, Kozo Kataoka, Takeshi Shioya, Toru Aoyama, Toshihisa Tamura, Rai Shimoyama, Atsuko Fukazawa, Kensuke Kumamoto, Naoyuki Yamashita, Yasuyuki Yokoyama, Suguru Hasegawa, Shuji Saito, Koich Okuya, Fumihiko Fujita, Nobuhiko Taniai, Masaki Kaibori, Daisuke Ichikawa：
Clinical Impact of Anti-adhesive Materials in Preventing Postoperative Small Bowel Obstruction After Gastrectomy for Gastric Cancer: A Multicenter Observational Study Including 2,077 Patients.
Anticancer research
46
(8)
：4545
-4553
, 2026
|
|
4.
|
Hiroya Iida, Hiroji Shinkawa, Hisashi Kosaka, Masaki Ueno, Haruki Mori, Koji Komeda, Satoshi Yasuda, Masahiko Kinoshita, Shinya Hayami, Masaji Tani, Masaki Kaibori, Shoji Kubo：
Postoperative Abscesses in the Liver Resection Plane in Patients with a History of Biliary Tract Treatments: A Multicenter Cohort Study.
Asian Pacific journal of cancer prevention : APJCP
27
(6)
：2043
-2052
, 2026
|
|
5.
|
Van Khanh Nguyen, Hisashi Kosaka, Kosuke Matsui, Hideyuki Matsushima, Hidekazu Yamamoto, Gozo Kiguchi, Takuya Ohigashi, Thanh Tung Lai, Hoang Hai Duong, Kyoko Inoue, Moriyasu Takada, Hiroki Kato, Kengo Yoshii, Takashi Ito, Tsukasa Ikeura, Makoto Naganuma, Masaki Kaibori：
Association Between Cumulative Chemotherapy Exposure and Survival Outcomes in Advanced Biliary Tract Cancer.
Cancers
18
(14)
：2263
, 2026
|
|
6.
|
Ryota Matsui, Kazuyoshi Yamamoto, Yoshiro Yukawa, Masayoshi Terayama, Yukinori Kurokawa, Daisuke Ichikawa, Yoshitomo Yanagimoto, Takashi Oshima, Souya Nunobe, Takashi Kamei, Hiroya Takeuchi, Yoshihiro Nabeya, Masaki Kaibori, Naoki Hiki, Hidetoshi Eguchi, Yuichiro Doki：
Identification of patients at risk for poor survival among those with normal skeletal muscle mass: a multicenter retrospective validation study in gastric cancer.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
29
(5)
：1140
-1149
, 2026
|
|
7.
|
Kaho Aoe, Toshifumi Tada, Atsushi Hiraoka, Tomomitsu Matono, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Takashi Nishimura, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Tanaka, Hidenori Toyoda, Chikara Ogawa, Takeshi Hatanaka, Satoru Kakizaki, Kazuhito Kawata, Naganuma Atsushi, Hisashi Kosaka, Hidekatsu Kuroda, Yutaka Yata, Hiroki Nishikawa, Michitaka Imai, Tomoko Aoki, Hironori Ochi, Hideyuki Tamai, Shohei Komatsu, Takanori Matsuura, Yoshihide Ueda, Soo Ki Kim, Hideko Ohama, Fujimasa Tada, Shinichiro Nakamura, Yoshiko Nakamura, Osamu Yoshida, Kazuhiro Nouso, Asahiro Morishita, Norio Itokawa, Tomomi Okubo, Taeang Arai, Akemi Tsutsui, Takuya Nagano, Shinya Fukunishi, Kazunari Tanaka, Yuichi Koshiyama, Yuki Kanayama, Hidenao Noritake, Hirayuki Enomoto, Kosuke Matsui, Masaki Kaibori, Jumpei Okamura, Takumi Fukumoto, Yoichi Hiasa, Masatoshi Kudo, Takashi Kumada,：
Optimizing bevacizumab exposure in atezolizumab-based therapy for unresectable hepatocellular carcinoma: A nationwide real-world study.
Hepatology (Baltimore, Md.)
：Online ahead of print
, 2026
|
|
8.
|
Fujimasa Tada, Atsushi Hiraoka, Hideko Ohama, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Tanaka, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Kazuhito Kawata, Atsushi Naganuma, Hisashi Kosaka, Tomomitsu Matono, Yoshihide Ueda, Hidekatsu Kuroda, Yutaka Yata, Hiroki Nishikawa, Michitaka Imai, Tomoko Aoki, Hironori Ochi, Jumpei Okamura, Hideyuki Tamai, Shinichiro Nakamura, Yoshiko Nakamura, Osamu Yoshida, Kazuhiro Nouso, Asahiro Morishita, Norio Itokawa, Tomomi Okubo, Taeang Arai, Akemi Tsutsui, Takuya Nagano, Kazunari Tanaka, Yuichi Koshiyama, Yuki Kanayama, Hidenao Noritake, Shohei Komatsu, Takumi Fukumoto, Takanori Matsuura, Soo Ki Kim, Hirayuki Enomoto, Kosuke Matsui, Masaki Kaibori, Yoichi Hiasa, Masatoshi Kudo, Takashi Kumada,：
Clinical Characteristics, Predictive Factors, and the Impact of Antithrombotic Therapy on Bleeding Events in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.
Hepatology research : the official journal of the Japan Society of Hepatology
：Online ahead of print
, 2026
|
|
9.
|
Kazunari Tanaka, Kunihiko Tsuji, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Toru Ishikawa, Kazuto Tajiri, Hironori Tanaka, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Kazuhito Kawata, Atsushi Naganuma, Hisashi Kosaka, Tomomitsu Matono, Yoshihide Ueda, Hidekatsu Kuroda, Yutaka Yata, Hiroki Nishikawa, Michitaka Imai, Tomoko Aoki, Hironori Ochi, Jumpei Okamura, Hideyuki Tamai, Shinichiro Nakamura, Yoshiko Nakamura, Osamu Yoshida, Kazuhiro Nouso, Asahiro Morishita, Norio Itokawa, Tomomi Okubo, Taeang Arai, Akemi Tsutsui, Takuya Nagano, Fujimasa Tada, Hideko Ohama, Yuichi Koshiyama, Yuki Kanayama, Hidenao Noritake, Shohei Komatsu, Takumi Fukumoto, Takanori Matsuura, Soo Ki Kim, Hirayuki Enomoto, Kosuke Matsui, Masaki Kaibori, Yoichi Hiasa, Masatoshi Kudo, Takashi Kumada,：
Impact of Intrahepatic Tumor Burden on Outcomes in Patients With Hepatocellular Carcinoma With Extrahepatic Metastases Treated With Atezolizumab Plus Bevacizumab.
Hepatology research : the official journal of the Japan Society of Hepatology
：Online ahead of print
, 2026
|
|
10.
|
Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Takashi Nishimura, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hidenori Toyoda, Chikara Ogawa, Takeshi Hatanaka, Satoru Kakizaki, Kazuhito Kawata, Atsushi Naganuma, Hisashi Kosaka, Tomomitsu Matono, Hidekatsu Kuroda, Yutaka Yata, Hiroki Nishikawa, Hironori Tanaka, Michitaka Imai, Tomoko Aoki, Hironori Ochi, Hideyuki Tamai, Shohei Komatsu, Yoshihide Ueda, Soo Ki Kim, Shintaro Takaki, Fujimasa Tada, Hideko Ohama, Shinichiro Nakamura, Takanori Matsuura, Yoshiko Nakamura, Osamu Yoshida, Kazuhiro Nouso, Asahiro Morishita, Norio Itokawa, Tomomi Okubo, Taeang Arai, Akemi Tsutsui, Takuya Nagano, Kazunari Tanaka, Yuichi Koshiyama, Yuki Kanayama, Hidenao Noritake, Jumpei Okamura, Hirayuki Enomoto, Kosuke Matsui, Masaki Kaibori, Tamami Abe, Yoichi Hiasa, Masatoshi Kudo, Takashi Kumada,：
Simplified BALAD (BALAD-S) Score as a Guide for First-Line Immune Checkpoint Inhibitor Selection for Unresectable Hepatocellular Carcinoma.
Hepatology research : the official journal of the Japan Society of Hepatology
：Online ahead of print
, 2026
|
|
11.
|
Hisashi Kosaka, Rie Sugimoto, Masahiko Kinoshita, Satoshi Yasuda, Satoru Kakizaki, Jun Sakata, Kiyonori Yamai, Takeshi Hatanaka, Yusuke Yamamoto, Toshifumi Sato, Toru Ishikawa, Takanori Morikawa, Jun Hanaoka, Haruki Mori, Hidenori Toyoda, Tsuyoshi Sanuki, Misaki Yokoi, Hiroyuki Shibata, Koji Fukuda, Kazuhito Kawata, Koji Amaya, Takashi Ito, Masaaki Hidaka, Atsushi Naganuma, Keishi Sugimachi, Masaki Kaibori：
Impact of TOPAZ-1 eligibility on the survival benefit of durvalumab plus gemcitabine-cisplatin in advanced biliary tract cancer: a multicenter real-world study.
Journal of gastroenterology
61
(8)
：1170
-1180
, 2026
|
|
12.
|
Tomomitsu Matono, Toshifumi Tada, Atsushi Hiraoka, Masashi Hirooka, Yoshiko Nakamura, Osamu Yoshida, Kazuya Kariyama, Kazuhiro Nouso, Joji Tani, Asahiro Morishita, Masanori Atsukawa, Norio Itokawa, Tomomi Okubo, Taeang Arai, Koichi Takaguchi, Akemi Tsutsui, Takuya Nagano, Ei Itobayashi, Takashi Nishimura, Shinya Fukunishi, Hirayuki Enomoto, Kunihiko Tsuji, Kazunari Tanaka, Toru Ishikawa, Kazuto Tajiri, Hironori Tanaka, Hidenori Toyoda, Yuichi Koshiyama, Chikara Ogawa, Takeshi Hatanaka, Yuki Kanayama, Satoru Kakizaki, Kazuhito Kawata, Hidenao Noritake, Atsushi Naganuma, Hisashi Kosaka, Kosuke Matsui, Masaki Kaibori, Hidekatsu Kuroda, Yutaka Yata, Hiroki Nishikawa, Michitaka Imai, Tomoko Aoki, Hironori Ochi, Hideyuki Tamai, Jumpei Okamura, Shohei Komatsu, Takanori Matsuura, Shinichiro Nakamura, Yoshihide Ueda, Soo Ki Kim, Hideko Ohama, Fujimasa Tada, Takumi Fukumoto, Yoichi Hiasa, Masatoshi Kudo, Takashi Kumada：
Outcomes of Patients With Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab in Real-World Clinical Practice Who Met or Did Not Meet the Inclusion Criteria for the Phase 3 HIMALAYA Trial.
Journal of gastroenterology and hepatology
41
(7)
：2138
-2149
, 2026
|
|
13.
|
Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Takashi Nishimura, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Tanaka, Hidenori Toyoda, Chikara Ogawa, Takeshi Hatanaka, Satoru Kakizaki, Kazuhito Kawata, Atsushi Naganuma, Hisashi Kosaka, Tomomitsu Matono, Hidekatsu Kuroda, Yutaka Yata, Hiroki Nishikawa, Michitaka Imai, Tomoko Aoki, Hironori Ochi, Hideyuki Tamai, Shohei Komatsu, Takanori Matsuura, Yoshihide Ueda, Soo Ki Kim, Hideko Ohama, Fujimasa Tada, Shinichiro Nakamura, Yoshiko Nakamura, Osamu Yoshida, Kazuhiro Nouso, Asahiro Morishita, Norio Itokawa, Tomomi Okubo, Taeang Arai, Akemi Tsutsui, Takuya Nagano, Shinya Fukunishi, Kazunari Tanaka, Yuichi Koshiyama, Yuki Kanayama, Hidenao Noritake, Hirayuki Enomoto, Kosuke Matsui, Masaki Kaibori, Jumpei Okamura, Takumi Fukumoto, Yoichi Hiasa, Masatoshi Kudo, Takashi Kumada, ,：
Real-World Comparison of First-Line Atezolizumab plus Bevacizumab and Durvalumab plus Tremelimumab for Unresectable Hepatocellular Carcinoma.
Liver cancer
：Online ahead of print
, 2026
|
|
14.
|
Tomomitsu Matono, Toshifumi Tada, Atsushi Hiraoka, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Takashi Nishimura, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Tanaka, Hidenori Toyoda, Chikara Ogawa, Takeshi Hatanaka, Satoru Kakizaki, Kazuhito Kawata, Atsushi Naganuma, Hisashi Kosaka, Hidekatsu Kuroda, Yutaka Yata, Hiroki Nishikawa, Michitaka Imai, Tomoko Aoki, Hironori Ochi, Hideyuki Tamai, Shohei Komatsu, Takanori Matsuura, Yoshihide Ueda, Soo Ki Kim, Hideko Ohama, Fujimasa Tada, Shinichiro Nakamura, Yoshiko Nakamura, Osamu Yoshida, Kazuhiro Nouso, Asahiro Morishita, Norio Itokawa, Tomomi Okubo, Taeang Arai, Akemi Tsutsui, Takuya Nagano, Shinya Fukunishi, Kazunari Tanaka, Yuichi Koshiyama, Yuki Kanayama, Hidenao Noritake, Hirayuki Enomoto, Kosuke Matsui, Masaki Kaibori, Jumpei Okamura, Takumi Fukumoto, Yoichi Hiasa, Masatoshi Kudo, Takashi Kumada; RELPEC Group and HCC 48 Group：
Lymphocyte-Monocyte Ratio Predicts the Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab.
Liver international
46
(4)
：e70570
, 2026
|
|
15.
|
Kazunari Tanaka, Kunihiko Tsuji, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Takashi Nishimura, Toru Ishikawa, Kazuto Tajiri, Hironori Tanaka, Hidenori Toyoda, Chikara Ogawa, Takeshi Hatanaka, Satoru Kakizaki, Kazuhito Kawata, Atsushi Naganuma, Hisashi Kosaka, Tomomitsu Matono, Yoshihide Ueda, Hidekatsu Kuroda, Yutaka Yata, Hiroki Nishikawa, Michitaka Imai, Tomoko Aoki, Hironori Ochi, Jumpei Okamura, Hideyuki Tamai, Shinichiro Nakamura, Yoshiko Nakamura, Osamu Yoshida, Kazuhiro Nouso, Asahiro Morishita, Norio Itokawa, Tomomi Okubo, Taeang Arai, Akemi Tsutsui, Takuya Nagano, Fujimasa Tada, Hideko Ohama, Yuichi Koshiyama, Yuki Kanayama, Hidenao Noritake, Shohei Komatsu, Takumi Fukumoto, Takanori Matsuura, Soo Ki Kim, Hirayuki Enomoto, Kosuke Matsui, Masaki Kaibori, Yoichi Hiasa, Masatoshi Kudo, Takashi Kumada,：
Baseline DCP May Modify Response to Atezolizumab-Bevacizumab Versus Durvalumab-Tremelimumab in Unresectable HCC.
Liver international : official journal of the International Association for the Study of the Liver
46
(8)
：e70803
, 2026
|
|
16.
|
Hiraoka A, Kudo M, Tada T, Hatanaka T, Kakizaki S, Kariyama K, Ohama H, Tsuji K, Ishikawa T, Takaguchi K, Itobayashi E, Toyoda H, Matono T, Yata Y, Ogawa C, Naganuma A, Tani J, Atsukawa M, Nishimura T, Tajiri K, Kawata K, Kosaka H, Kuroda H, Hirooka M, Nishikawa H, Tada F, Nakamura S, Kanayama Y, Nouso K, Tanaka H, Tanaka K, Imai M,
Tsutsui A, Nagano T, Aoki T, Koshiyama Y, Morishita A, Itokawa N, Okubo T, Arai T, Fukunishi S, Noritake H, Nakamura Y, Yoshida O, Enomoto H, Kaibori M, Hiasa Y, Kumada T; Real-life Practice Experts for HCC.：
The Current Status of Tumor Markers as Biomarkers in the Era of Immunotherapy for Hepatocellular Carcinoma: Alpha-Fetoprotein Alone Is Not Sufficient.
Oncology
104
(1)
：79
-91
, 2026
|
|
17.
|
Van Nguyen, Khanh; Matsui, Kosuke; Kosaka, Hisashi; Matsushima, Hideyuki; Yamamoto, Hidekazu; Lai, Tung Thanh; Inoue, Kyoko; Takada, Moriyasu; Tada, Fujimasa; Hiraoka, Atsushi; Hatanaka, Takeshi; Tada, Toshifumi; Kumada, Takashi; Kato, Hiroki; Yoshii, Kengo; Yamaguchi, Takashi; Shimoda, Shinji; Naganuma, Makoto; Kaibori, Masaki：
Cachexia Index as a Prognostic Indicator in Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy.
Oncology
104
(2)
：113
-124
, 2026
|
|
18.
|
Ohama, Hideko; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Toyoda, Hidenori; Koshiyama, Yuichi; Ogawa, Chikara; Nishikawa, Hiroki; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Noritake, Hidenao; Kawata, Kazuhito; Naganuma, Atsushi; Kosaka, Hisashi; Matsui, Kosuke; Matono, Tomomitsu; Kuroda, Hidekatsu; Yata, Yutaka; Tanaka, Hironori; Aoki, Tomoko; Tamai, Hideyuki; Tada, Fujimasa; Kanayama, Yuki; Tanaka, Kazunari; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Miyake, Teruki; Yoshida, Osamu; Imai, Michitaka; Nakamura, Shinichiro; Enomoto, Hirayuki; Kaibori, Masaki; Kudo, Masatoshi; Hiasa, Yoichi; Kumada, Takashi：
Limited Prognostic Impact of Sustained Virologic Response on Atezolizumab plus Bevacizumab Therapy for HCV-Related Unresectable Hepatocellular Carcinoma.
Oncology
104
(5)
：487
-496
, 2026
|
|
19.
|
Thanh Tung Lai, Kosuke Matsui, Hisashi Kosaka, Hideyuki Matsushima, Hidekazu Yamamoto, Gozo Kiguchi, Takuya Ohigashi, Van Khanh Nguyen, Hoang Hai Duong, Kyoko Inoue, Moriyasu Takada, Kengo Yoshii, Masaki Kaibori：
Laparoscopic versus open sectionectomy and bisectionectomy for hepatocellular carcinoma: a propensity score-matched analysis of short- and long-term outcomes.
Surgical endoscopy
：Online ahead of print
, 2026
|
|
症例報告
|
|
1.
|
Richi Nakatake, Hiroaki Kitade, Hidesuke Yanagida, Morihiko Ishizaki, Tetsuya Okuyama, Yoshiko Uemura, Sohei Satoi：
Extremely large solid pseudopapillary neoplasm of the pancreas.
Clinical journal of gastroenterology
19
(5)
：1193
-1198
, 2026
|
|
その他
|
|
1.
|
岡本 朋美, 井ノ上 恭子, 高田 守康, 海堀 昌樹：
【医療・介護における経口的栄養補助(Oral Nutritional Supplements)】肝臓外科におけるOral Nutritional Supplements(ONS)の目的と意義.
機能性食品と薬理栄養
19
(5)
：281
-288
, 2026
|
|
2.
|
高橋 大五郎, 小坂 久, 大東 拓哉, 吉川 潤一, 松島 英之, 木口 剛造, 山本 栄和, 松井 康輔, 海堀 昌樹：
【高齢者手術の適応と周術期管理】高齢者に対する肝切除の適応判断と周術期管理 年齢ではなく「機能」で判断する.
消化器外科
49
(6)
：599
-606
, 2026
|
|
3.
|
小坂 久, 海堀 昌樹：
【肝門部領域胆管癌のすべて-術前管理から術後長期管理まで】術中・術後管理 仮性動脈瘤 肝門部領域胆管癌術後に発生した肝動脈仮性動脈瘤に対する止血と肝血流維持の治療戦略.
臨床外科
81
(2)
：317
-322
, 2026
|
|
4.
|
Yuta Ushida, Ken Hayashi, Gozo Kiguchi, Akinari Miyazaki：
Robotic distal pancreatectomy with splenectomy using a novel retroperitoneal-first laparoscopic approach after Billroth I reconstruction: overcoming adhesions following gastrectomy.
Surgical oncology
68
：102527
, 2026
|
|
■ 学会発表
|
国際学会及び海外の学会
|
|
1.
|
◎小坂久：
GCD治療における患者選択の重要性：TOPAZ-1適格性とリアルワールドアウトカム.
BTC Webシンポジウム,
Zooｍ配信,
2026/05
|
|
全国規模の学会
|
|
1.
|
◎小坂久, 木下正彦, 山本有祐, 安田里司, 森治樹, 米田浩二, 相原司, 新川寛二, 上野昌樹, 海堀昌樹：
技術的・腫瘍学的・機能的因子に基づく Borderline resectable 肝内胆管癌の定義と治療戦略.
第81回日本消化器外科学会総会,
横浜,
2026/07
|
|
2.
|
◎山本栄和, 大東拓哉 吉川潤一, 松島英之, 高橋大五郎, 木口剛造, 小坂久, 松井康輔, 海堀昌樹：
Borderline resectable 肝細胞癌に対する治療戦略－ICIを軸とした外科的介入の再定義－.
第81回日本消化器外科学会総会,
横浜,
2026/07
|
|
3.
|
◎新川寛二, 海堀昌樹, 石沢武彰：
CT画像の深層学習を活用したAIによる肝細胞癌術後予測モデルの多施設データでの検証.
第62回 日本肝臓学会総会,
新潟県新潟市,
2026/06
|
|
4.
|
◎田中瑛美, 多田俊史, 熊田卓, 平岡淳, 谷丈二, 厚川正則, 高口浩一, 糸林詠, 辻邦彦, 石川達, 豊田秀徳, 畑中健, 柿﨑暁, 玉井秀幸, 狩山和也, 能祖一裕, 中村進一郎, 海堀昌樹, 日浅陽一, 工藤正俊：
肝細胞癌におけるアテゾリズマブ/ベバシズマブ投与例のアウトカム：体重換算に対するベバシズマブ投与量のインパクト.
第62回 日本肝臓学会総会,
新潟県新潟市,
2026/06
|
|
5.
|
◎山本栄和, 大東拓哉, 吉川潤一, 松島英之, 木口剛造, 小坂久, 山口隆志, 志波俊輔, 山敷宜代, 下田慎治, 松井康輔, 海堀昌樹：
進行肝細胞癌に対するICI sequential therapy の治療成績.
第34回日本肝がん分子標的治療研究会,
愛媛,
2026/06
|
|
6.
|
◎田中一成, 辻邦彦, 平岡淳, 多田俊史, 畑中健, 的野智光, 狩山和也, 糸林詠, 高口浩一, 矢田豊, 川田一仁, 石川達, 厚川正則, 黒田英克, 田尻和人, 柿崎暁, 海堀昌樹, 日浅陽一, 工藤正俊, 熊田卓：
切除不能肝細胞癌における CLEAR score がAtez/Bev と Dur/Tre の奏効・病勢コントロールの予後的意義に与える影響.
第34回日本肝がん分子標的治療研究会,
愛媛,
2026/06
|
|
7.
|
◎平岡淳, 多田俊史, 畑中健, 田中一成, 柿崎暁, 小松昇平, 豊田秀徳, 田尻和人, 石川達, 黒田英克, 玉井秀幸, 越智裕紀, 的野智光, 筒井朱美, 谷丈二, 能祖一裕, 海堀昌樹, 日浅陽一, 工藤正俊, 熊田卓：
初回全身薬物療法ICIレジメンの使い分けにおけるBALADスコアの有用性.
第34回日本肝がん分子標的治療研究会,
愛媛,
2026/06
|
|
8.
|
◎小坂久：
「SIXPADで切り拓く新たなサルコペニア対策」.
第126回日本外科学会定期学術集会,
札幌,
2026/04
|
|
9.
|
◎小坂久, 木下正彦, 安田里司, 坂田純, 山本有祐, 森川孝則, 森治樹, 日高匡章, 杉町圭史, 海堀昌樹：
国内多施設共同研究データに基づく切除不能肝門部胆管癌に対する薬物療法後のコンバーション手術の現況.
第126回日本外科学会定期学術集会,
札幌,
2026/04
|
|
10.
|
◎山本栄和, 大東拓哉, 松島英之, 吉川潤一, 木口剛造, 小坂久, 松井康輔, 海堀昌樹：
腫瘍学的切除可能性分類からみた肝細胞癌治療戦略：BR症例におけるConversion surgery の臨床的意義.
第126回日本外科学会定期学術集会,
札幌,
2026/04
|
|
11.
|
◎松井康輔, 松島英之, 木口剛造, 小坂久, 山本栄和, 海堀昌樹：
肝切除中の出血性トラブルとその対処法.
第126回日本外科学会定期学術集会,
札幌,
2026/04
|
|
12.
|
◎新川寛二, 植田大樹, 木下正彦, 西尾康平, 木村健二郎, 海堀昌樹, 速水晋也, 安田里司, 森村怜, 相原司, 登千穂子, 石沢武彰：
AIによる深層学習を活用した肝細胞癌の術前CT画像を用いた術後成績の予測.
第126回日本外科学会定期学術集会,
札幌,
2026/04
|
|
その他
|
|
1.
|
◎小坂久：
外科医が考える切除不能胆道癌治療の最前線～GCDを中心とした治療戦略～.
BTC Webシンポジウム,
Zooｍ配信,
2026/05
|
|
